Source: ERS Courses: Interstitial Lung Diseases
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Michael Kreuter (Heidelberg, Germany). Comorbidities in ILDs. ERS Courses: Interstitial Lung Diseases

Member's Comments

No comment yet.

Related content which might interest you: Comorbidities in COPD Source: Eur Respir J 2009; 34: 1497-1498 Year: 2009 Comorbidities of COPD Source: Eur Respir Rev 2013; 22: 454-475 Year: 2013 ILDs and COVID-19 Source: COVID-19 Videos Year: 2020 Comorbidities in interstitial lung diseases Source: Eur Respir Rev 2017; 26: 160027 Year: 2017 COPD Phenotypes and Comorbidities Source: International Congress 2017 – COPD biomarkers Year: 2017 Pulmonary Hypertension and cardiovascular disease in ILDs Source: School Course 2014 - Interstitial lung diseases Year: 2014 Impact of comorbidities and etiology of bronchiectasis on outcomes in hospitalised patients with bronchiectasis Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD Year: 2015 Comorbidities in severe asthma Source: International Congress 2019 – State of the art session: Airway disease Year: 2019 Comorbidities and the ageing lung Source: Research Seminar 2013 - ERS Presidential Summit on Research gaps, patient needs and innovative solutions: a forward look on lung health research Year: 2013 GERD in ILDs Source: ERS Course 2016 Year: 2016 GERD in ILDs Source: ERS Course 2019 - Interstitial Lung Diseases Year: 2018 Positive microbiology findings in non-cystic fibrosis bronchiectasis and co-morbidities Source: International Congress 2016 – Clinical and microbiological aspects of bronchiectasis and non-tuberculous mycobacterium (NTM) infections Year: 2016 Impact of co-morbidities on disease severity and risk of mortality in non-cystic fibrosis bronchiectasis Source: International Congress 2015 – Adult bronchiectasis: risk factors and future perspectives Year: 2015 Comorbidities in unclassifiable interstitial lung disease Source: Virtual Congress 2020 – Addressing unresolved questions in rare diffuse parenchymal lung diseases: interdisciplinary research is the key Year: 2020 Outcomes in interstitial lung diseases (ILDs) Source: Eur Respir J 2005; 26: Suppl. 49, 268s Year: 2005 Monitoring of ILDs Source: School Course 2014 - Interstitial lung diseases Year: 2014 Drug-induced ILDs Source: ERS Courses: Interstitial Lung Diseases Year: 2019 Prevalence of COPD in vascular diseases Source: International Congress 2015 – Prevalence of respiratory disease Year: 2015 Comorbidities – should we and how should we treat them in asthma and COPD? Source: International Congress 2014 – PG02 Current clinical problems in pulmonology Year: 2014